Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy

Transfusion

Volumn 54, Issue 12, 2014, Pages 3036-3042

  De Clippel, Dorien ^a   Baeten, Martine ^a   Torfs, Anneleen ^a   Emonds, Marie Paule ^a   Feys, Hendrik B ^a   Compernolle, Veerle ^a   Vandekerckhove, Philippe ^a,b  

^a Rode Kruis Vlaanderen   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; ALLOANTIBODY; HLA ANTIGEN;

ADULT; AGED; ALLOIMMUNIZATION; ARTICLE; DISEASE ASSOCIATION; DONOR; ERYTHROCYTE TRANSFUSION; FEMALE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSED ABORTION; NULLIPARA; PARITY; PREGNANCY; PREVALENCE; RISK FACTOR; RISK REDUCTION; THROMBOCYTOPHERESIS; TRANSFUSION RELATED ACUTE LUNG INJURY; BLOOD; BLOOD DONOR; CLINICAL TRIAL; DONOR SELECTION; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; PROCEDURES; THROMBOCYTE TRANSFUSION;

BLOOD DONORS; DONOR SELECTION; FEMALE; FETOMATERNAL TRANSFUSION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MALE; PLATELET TRANSFUSION; PLATELETPHERESIS; PREGNANCY;

EID: 84916608594     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12727     Document Type: Article

References (26)

1. Popovsky MA, Moore SB,. Diagnostic and pathogenetic considerations in transfusion-related acute long injury. Transfusion 1985; 25: 573-577.
2. Zupanska B, Uhrynowska M, Michur H, et al. Transfusion-related acute lung injury and leukocyte-reacting antibodies. Vox Sang 2007; 93: 70-77.
3. Kopko PM, Popovsky MA, MacKenzie MR, et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001; 41: 1244-1248.
4. Bux J, Becker F, Seeger W, et al. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 1996; 93: 707-713.
5. Reil A, Wesche J, Greinacher A, et al. Geno- and phenotyping and immunogenicity of HNA 3. Transfusion 2011; 51: 18-24.
6. Sachs UJH, Wasel W, Bayat B, et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 2011; 117: 669-677.
7. Reil A, Keller-Stanislawski B, Günay S, et al. Specificities of leukocyte alloantibodies in transfusion-related acute lung injury and results of leukocyte antibody screening of blood donors. Vox Sang 2008; 95: 313-317.
8. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012; 119: 1757-1767.
9. Gajic O, Rana R, Winters JL, et al. Transfusion-related acute lung injury in the critically ill. Am J Respir Crit Care Med 2007; 176: 886-891.
10. Kleinman SH, Triulzi DJ, Murphy EL, et al. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components. Transfusion 2011; 51: 2078-2091.
11. US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion, annual summary for fiscal year 2010. Rockville (MD): Center for Biologics Evaluation and Research, US Food and Drug Administration; 2012.
12. Rana R, Fernandez-Perez ER, Khan SA, et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46: 1478-1483.
13. Serious Hazards of Transfusion Steering Committee. Serious hazards of transfusion: annual report 2000-2001; p. 94-101. Manchester (UK): SHOT Office; 2002. [cited 2014 May 8]. Available from: http://www.shotuk.org/wp-content/uploads/2010/03/SHOT-Report-00-01.pdf.
14. Eder AF, Herron R, Strupp A, et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007; 47: 599-607.
15. Bux J,. Leucocyte antibody screening of donors for the prevention of TRALI. ISBT Sci Ser 2009; 4: 251-253.
16. Eder AF, Herron RM, Strupp A, et al. Effective reduction of transfusion-related acute lung injury risk with male predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 2010; 50: 1732-1742.
17. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49: 440-452.
18. Carrick DM, Johnson B, Kleinman SH, et al. Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff. Transfusion 2011; 51: 1105-1116.
19. Powers A, Stowell CP, Dzik WH, et al. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008; 48: 2549-2558.
20. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-1835.
21. Kakaiya RM, Triulzi DJ, Wright DJ, et al. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010; 50: 1328-1334.
22. Middelburg RA, Porcelijn L, Lardy N, et al. Prevalence of leukocyte antibodies in the Dutch donor population. Vox Sang 2011; 100: 327-335.
23. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009; 9: 55.
24. Balki M, Dhumne S, Kasodekar S, et al. Blood transfusion for primary postpartum hemorrhage: a tertiary care hospital review. J Obstet Gynaecol Can 2008; 30: 1002-1007.
25. Jakobsson M, Gissler M, Tapper AM,. Risk factors for blood transfusion at delivery in Finland. Acta Obstet Gynecol Scand 2012; 92: 414-420.
26. Holm C, Langhoff-Roos J, Petersen KB, et al. Severe postpartum haemorrhage and mode of delivery: a retrospective cohort study. BJOG 2012; 119: 596-604.